Total Payments
$15,564
2024 Payments
$2,455
Companies
67
Transactions
865
Medicare Patients
8,140
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$15,076 (96.9%)
Education$296.09 (1.9%)
Travel$192.28 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,076 | 857 | 96.9% |
| Education | $296.09 | 7 | 1.9% |
| Travel and Lodging | $192.28 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,884 | 95 | $0 (2024) |
| ABBVIE INC. | $1,597 | 75 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,380 | 68 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $977.59 | 103 | $0 (2021) |
| Horizon Therapeutics plc | $784.25 | 59 | $0 (2022) |
| Novo Nordisk Inc | $690.96 | 52 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $688.91 | 47 | $0 (2024) |
| Lilly USA, LLC | $598.95 | 34 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $478.19 | 22 | $0 (2024) |
| Incyte Corporation | $465.98 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,455 | 96 | ABBVIE INC. ($352.46) |
| 2023 | $2,361 | 105 | ABBVIE INC. ($614.99) |
| 2022 | $2,022 | 106 | ABBVIE INC. ($283.18) |
| 2021 | $2,133 | 117 | AbbVie Inc. ($346.40) |
| 2020 | $1,683 | 96 | AstraZeneca Pharmaceuticals LP ($244.73) |
| 2019 | $1,413 | 103 | AstraZeneca Pharmaceuticals LP ($232.67) |
| 2018 | $1,729 | 129 | Sunovion Pharmaceuticals Inc. ($373.90) |
| 2017 | $1,769 | 113 | SANOFI-AVENTIS U.S. LLC ($527.41) |
All Payment Transactions
865 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.79 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/11/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/07/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,773 | 6,404 | $661,961 | $458,332 |
| 2022 | 34 | 1,943 | 7,096 | $744,184 | $474,237 |
| 2021 | 34 | 2,051 | 7,696 | $779,643 | $500,194 |
| 2020 | 35 | 2,373 | 9,245 | $834,006 | $541,856 |
Total Patients
8,140
Total Services
30,441
Medicare Billing
$2.0M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 160 | 1,862 | $181,472 | $127,285 | 70.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 160 | 1,002 | $123,246 | $97,908 | 79.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 801 | $141,370 | $88,774 | 62.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 143 | 452 | $35,312 | $21,880 | 62.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 116 | 137 | $23,608 | $16,947 | 71.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $13,935 | $11,738 | 84.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 152 | $14,808 | $10,978 | 74.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 24 | 209 | $17,333 | $8,760 | 50.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 49 | $13,170 | $7,464 | 56.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 60 | 66 | $9,483 | $7,223 | 76.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 126 | $10,990 | $7,157 | 65.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 53 | 219 | $8,067 | $6,660 | 82.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 46 | 59 | $8,357 | $6,346 | 75.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 145 | $10,356 | $6,258 | 60.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 41 | 41 | $7,175 | $5,363 | 74.7% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 15 | 15 | $4,155 | $3,792 | 91.3% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 22 | 36 | $5,156 | $3,507 | 68.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $3,683 | $3,103 | 84.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 137 | 327 | $4,905 | $2,747 | 56.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 72 | $2,880 | $2,591 | 90.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,217 | $2,393 | 56.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 46 | $2,451 | $1,933 | 78.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 55 | 56 | $1,960 | $1,921 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 68 | 141 | $7,020 | $1,788 | 25.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 69 | 71 | $2,840 | $1,450 | 51.1% |
About Dr. Mohammad Hussain, M.D
Dr. Mohammad Hussain, M.D is a Internal Medicine healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710051537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Hussain, M.D has received a total of $15,564 in payments from pharmaceutical and medical device companies, with $2,455 received in 2024. These payments were reported across 865 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($15,076).
As a Medicare-enrolled provider, Hussain has provided services to 8,140 Medicare beneficiaries, totaling 30,441 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Amityville, NY
- Active Since 11/20/2006
- Last Updated 08/28/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710051537
Products in Payments
- FARXIGA (Drug) $1,163
- VRAYLAR (Drug) $1,075
- XIFAXAN (Drug) $725.67
- PENNSAID (Drug) $689.02
- TOUJEO (Drug) $599.32
- JARDIANCE (Drug) $563.12
- LONHALA MAGNAIR (Drug) $455.83
- QULIPTA (Drug) $386.18
- Victoza (Drug) $366.28
- Kerendia (Drug) $329.81
- SOLIQUA 100/33 (Biological) $312.61
- XARELTO (Drug) $299.87
- ENTRESTO (Drug) $298.41
- UTIBRON (Drug) $286.44
- ELIQUIS (Drug) $283.11
- BREZTRI (Drug) $275.13
- TRULICITY (Drug) $247.90
- REXULTI (Drug) $241.06
- Vascepa (Drug) $234.73
- YUPELRI (Drug) $232.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Amityville
Dr. Mathew Chengot, M.d, M.D
Internal Medicine — Payments: $26,102
Internal Medicine $26,102
Dr. Edison Gavilanes, Md, MD
Internal Medicine — Payments: $14,498
Internal Medicine $14,498
Dr. Vinod Gulati, M.d, M.D
Internal Medicine — Payments: $10,734
Internal Medicine $10,734
Dr. Brian Galler, D.o, D.O
Internal Medicine — Payments: $4,837
Internal Medicine $4,837
Piya Ghoshal, M.d, M.D
Internal Medicine — Payments: $4,783
Internal Medicine $4,783
Dr. Brijesh Goyal, M.d, M.D
Internal Medicine — Payments: $3,506
Internal Medicine $3,506